Michael D. Aldridge
Insider
First SEC filing: Feb. 23, 2018 · Latest: Feb. 23, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2018 | CDXS | M 10b5-1 | 22,000 | · | · | 206,000 Direct | -9.65% | Disposed | (price as of 2026-10-05) |
| May 17, 2018 | CDXS | S 10b5-1 | 22,000 | $13.54 | $297,880 | 0 Direct | -100.00% | Disposed | -90.1% (price as of 2026-10-05) |
| May 17, 2018 | CDXS | M 10b5-1 | 22,000 | $4.37 | $96,140 | 22,000 Direct | · | Acquired | -69.3% (price as of 2026-10-05) |
| May 15, 2018 | CDXS | M 10b5-1 | 22,000 | · | · | 228,000 Direct | -8.80% | Disposed | (price as of 2026-10-05) |
| May 15, 2018 | CDXS | S 10b5-1 | 22,000 | $12.91 | $284,020 | 0 Direct | -100.00% | Disposed | -89.6% (price as of 2026-10-05) |
| May 15, 2018 | CDXS | M 10b5-1 | 22,000 | $4.37 | $96,140 | 22,000 Direct | · | Acquired | -69.3% (price as of 2026-10-05) |
| Feb. 21, 2018 | CDXS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 20, 2018 | CDXS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 5, 2018 | CDXS | A | 167,750 | · | · | 167,750 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 3, 2017 | CDXS | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 16, 2016 | CDXS | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 17, 2018 | CDXS | Stock Option (Right to Buy) | Common Stock | $4.37 | Oct. 15, 2026 | 22,000 | Disposed |
| May 15, 2018 | CDXS | Stock Option (Right to Buy) | Common Stock | $4.37 | Oct. 15, 2026 | 22,000 | Disposed |
| Feb. 21, 2018 | CDXS | Stock Option (Right to Buy) | Common Stock | $9.05 | Feb. 21, 2028 | 60,000 | Acquired |
| Feb. 20, 2018 | CDXS | Stock Option (Right to Buy) | Common Stock | · | Feb. 20, 2028 | 60,000 | Acquired |
| Feb. 5, 2018 | CDXS | Stock Option (Right to Buy) | Common Stock | $4.60 | Feb. 2, 2027 | 167,750 | Acquired |
| Feb. 3, 2017 | CDXS | Stock Options (Right to Buy) | Common Stock | $4.60 | Feb. 3, 2027 | 125,000 | Acquired |
| Oct. 16, 2016 | CDXS | Stock Option (Right to Buy) | Common Stock | $4.37 | Oct. 15, 2026 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $283,344 | · | · | · | · | · | $234,148 | $1,295,990 |
| 2017 | $390,833 | · | · | · | $196,000 | · | $12,040 | $1,234,223 |
| 2016 | $79,167 | · | · | · | $43,000 | · | $2,845 | $718,237 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.